DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Heparin (Heparin Sodium) - Published Studies


Heparin Related Published Studies

Well-designed clinical trials related to Heparin

Is there evidence that fresh frozen plasma is superior to antithrombin administration to treat heparin resistance in cardiac surgery? [2014]

Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial. [2014]

Low-molecular-weight heparin biosimilars: potential implications for clinical practice. Australian Low-Molecular-Weight Heparin Biosimilar Working Group (ALBW). [2014]

Comparison of heparinized saline and 0.9% sodium chloride for maintaining peripheral intravenous catheter patency in dogs. [2013]

Heparin for assisted reproduction. [2013]

Comparison of aspirin plus heparin with heparin alone on asymptomatic perioperative deep vein thrombosis in candidates for elective off-pump coronary artery bypass graft: a randomized clinical trial. [2013]

Anti-inflammatory effect of low-molecular-weight heparin in pediatric cataract surgery: a randomized clinical trial. [2012]

Alkalinized lidocaine and heparin provide immediate relief of pain and urgency in patients with interstitial cystitis. [2012]

Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high-dose vs. low-dose heparin protocols. [2011.12]

Comparison of enoxaparin and unfractionated heparin in endovascular interventions for the treatment of peripheral arterial occlusive disease: a randomized controlled trial. [2011.11]

Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. [2011.08.20]

A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. [2011.08.02]

Unfractionated heparin for second trimester placental insufficiency: a pilot randomized trial. [2011.08]

SUrgical versus PERcutaneous Bypass: SUPERB-trial; Heparin-bonded endoluminal versus surgical femoro-popliteal bypass: study protocol for a randomized controlled trial. [2011.07.18]

What is the effect of low-molecular weight heparin for venous thromboembolism prophylaxis compared with mechanical methods, on the occurrence of hemorrhagic and venous thromboembolic complications in patients with intracerebral hemorrhage? A critically appraised topic. [2011.07]

Is the ACT two minutes after heparin injection reliable? [2011.07]

Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: the Innohep(R) in Renal Insufficiency Study (IRIS). [2011.07]

The role of low-molecular-weight heparin in recurrent implantation failure: a prospective, quasi-randomized, controlled study. [2011.06.30]

Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. [2011.06.25]

A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: the tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial. [2011.06.01]

Effect of topical heparin and levomenol on atopic dermatitis: a randomized four-arm, placebo-controlled, double-blind clinical study. [2011.06]

Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer. [2011.05.20]

The Scandinavian Propaten((R)) trial - 1-year patency of PTFE vascular prostheses with heparin-bonded luminal surfaces compared to ordinary pure PTFE vascular prostheses - a randomised clinical controlled multi-centre trial. [2011.05]

[Clinical observation of lower extremity deep venous hrombosis (DVT) postoperative fracture treated by Maixuekang capsule and low molecular heparin calcium (Subilin)]. [2011.04]

Safety assessment and pharmacodynamics of a novel ultra low molecular weight heparin (RO-14) in healthy volunteers--a first-time-in-human single ascending dose study. [2011.04]

Lipid-heparin infusion suppresses the IL-10 response to trauma in subcutaneous adipose tissue in humans. [2011.04]

The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients. [2011.03]

Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome. [2011.03]

Heparin versus tirofiban in microvascular anastomosis: randomized controlled trial in a rat model. [2011.02]

Certoparin versus unfractionated heparin to prevent venous thromboembolic events in patients hospitalized because of heart failure: a subgroup analysis of the randomized, controlled CERTIFY study. [2011.02]

Diffusion-weighted magnetic resonance imaging for the detection of ischemic brain lesions in coronary artery bypass graft surgery: relation to extracorporeal circulation and heparinization. [2011.02]

Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome. [2011.02]

A preventive effect of unfractionated heparin on post-ERCP pancreatitis is suggested by positive effects on laboratory markers. [2011.01]

Percutaneous transvenous mitral commissurotomy: with or without heparin? A randomised double blind study. [2011]

Diclofenac epolamine plus heparin plaster versus diclofenac epolamine plaster in mild to moderate ankle sprain: a randomized, double-blind, parallel-group, placebo-controlled, multicentre, phase III trial. [2011]

Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin. [2011]

Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis. [2010.12.06]

Hyaluronan based heparin free coated open and closed extracorporeal circuits for high risk coronary revascularization. [2010.12]

Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): a randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes initially treated with fondaparinux. [2010.12]

Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass. [2010.11.23]

A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: The tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial. [2010.11.08]

Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy. [2010.11]

Heparin for patients with growth restricted fetus: a prospective randomized controlled trial. [2010.09]

Usefulness of intravenous heparin to prevent thrombosis of central venous catheter in children. [2010.09]

Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial. [2010.08]

A randomised, controlled trial of heparin in total parenteral nutrition to prevent sepsis associated with neonatal long lines: the Heparin in Long Line Total Parenteral Nutrition (HILLTOP) trial. [2010.07]

Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands. [2010.07]

A continuous heparin infusion does not prevent catheter-related thrombosis in infants after cardiac surgery. [2010.07]

PRODIGE: a randomized placebo-controlled trial of dalteparin low molecular weight heparin (LMWH) thromboprophylaxis in patients with newly diagnosed malignant glioma. [2010.06.28]

A randomized, double-blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non-surgical patients: CERTIFY Study. [2010.06]

Patency of arteriovenous fistula for dialysis improbe with topical spraygel heparin. [2010.06]

SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. [2010.05.27]

Treatment of immune-mediated hemolytic anemia with individually adjusted heparin dosing in dogs. [2010.05]

Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes. [2010.05]

Effect of lower-molecular weight heparin in the prevention of pancreatic encephalopathy in the patient with severe acute pancreatitis. [2010.05]

Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. [2010.04.29]

Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial. [2010.04.20]

Comparison of bivalirudin and unfractionated heparin plus protamine in patients with coronary heart disease undergoing percutaneous coronary intervention (from the Antithrombotic Regimens aNd Outcome [ARNO] trial). [2010.04.15]

Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis. [2010.04]

The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia. [2010.03.04]

Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin. [2010.03]

Clinical performance and biocompatibility of hyaluronan-based heparin-bonded extracorporeal circuits in different risk cohorts. [2010.03]

Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists? [2010.03]

Coagulation-fibrinolysis changes during off-pump bypass: effect of two heparin doses. [2010.02]

Inflammatory biomarker profiling in elderly patients with acute hip fracture treated with heparins. [2010.02]

[Appropriate dosage of unfraction heparin and low molecular weight heparin in hemodialysis patients] [2010.01.19]

Bleeding after percutaneous coronary intervention with Bivalirudin or unfractionated Heparin and one-year mortality. [2010.01.15]

Enoxaparin versus unfractioned heparin as anticoagulant for continuous venovenous hemodialysis: a randomized open-label trial. [2010.01]

Comparison between standard heparin and tinzaparin for haemodialysis catheter lock. [2010.01]

Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery. [2010.01]

A combinative effect of low-molecular-weight heparin and intermittent pneumatic compression device for thrombosis prevention during laparoscopic fundoplication. [2010]

Efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome. [2010]

Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy. [2010]

Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial. [2010]

A plaster containing DHEP and heparin for mild to moderate contusions and sprains with haematoma: a double-blind randomized study. [2010]

A randomised, controlled trial of heparin in total parenteral nutrition to prevent sepsis associated with neonatal long lines: the Heparin in Long Line Total Parenteral Nutrition (HILLTOP) trial. [2010]

One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial. [2010]

Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: a Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment - Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial. [2009.12]

Comparison of bivalirudin monotherapy versus unfractionated heparin plus tirofiban in patients with diabetes mellitus undergoing elective percutaneous coronary intervention. [2009.11.01]

Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial. [2009.11]

Comparison of the effect of intra-arterial versus intravenous heparin on radial artery occlusion after transradial catheterization. [2009.10.15]

Safety of low-dose heparin for intracranial stent-assisted angioplasty: a randomized controlled pilot study. [2009.10]

Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients. [2009.08.20]

A comparison of anticoagulation with bivalirudin and provisional GPIIb/IIIa inhibition with unfractionated heparin and mandatory GPIIb/IIIa inhibition during percutaneous coronary intervention in relation to platelet activation and the inhibition of coagulation. [2009.08]

Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: results of the STACK-on to ENOXaparin (STACKENOX) study. [2009.08]

Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial. [2009.07]

[Evaluation of clinical effects on low-dose heparin therapy for sepsis] [2009.07]

Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. [2009.06]

Low molecular weight heparin significantly reduces embolisation after carotid endarterectomy--a randomised controlled trial. [2009.06]

Comparison of posterior capsular opacification in heparin-surface-modified hydrophilic acrylic and hydrophobic acrylic intraocular lenses. [2009.05]

Randomized, prospective trial comparing bridging therapy using low-molecular-weight heparin with maintenance of oral anticoagulation during extraction of teeth. [2009.05]

A randomized controlled clinical trial of the use of benazepril and heparin for the treatment of chronic kidney disease in dogs. [2009.04.15]

Low molecular weight heparin in the treatment of severe acute pancreatitis: a multiple centre prospective clinical study. [2009.04]

A comparison of low-molecular-weight heparin and combined therapy of low-molecular-weight heparin with an anti-inflammatory agent in the treatment of superficial vein thrombosis. [2009.04]

Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study). [2009.04]

AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery--TREK: a dose-ranging study. [2009.04]

Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction. [2009.03.10]

Heparin-bonded central venous catheters do not reduce thrombosis in infants with congenital heart disease: a blinded randomized, controlled trial. [2009.03]

A randomised open-label trial comparing long-term sub-cutaneous low-molecular-weight heparin compared with oral-anticoagulant therapy in the treatment of deep venous thrombosis. [2009.03]

Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome. [2009.03]

Low Molecular Weight Heparin and Aspirin for Recurrent Pregnancy Loss: Results from the Randomized, Controlled HepASA Trial. [2009.02.04]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017